Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
Covington
Cipla
Dow
Chinese Patent Office
Cerilliant
Healthtrust
Citi

Generated: February 16, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for METFORMIN ER

« Back to Dashboard

Payment Methods and Pharmacy Types for METFORMIN ER (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $235,393,405
INSIDE ANOTHER STORE $202,948,186
[disabled in preview] $178,967,776
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 174,395
INSIDE ANOTHER STORE 392,572
[disabled in preview] 417,776
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $31,821,662
MEDICARE $132,484,722
[disabled in preview] $453,002,983
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for METFORMIN ER
Drug Units Sold Trends for METFORMIN ER

Annual Sales Revenues and Units Sold for METFORMIN ER

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
METFORMIN ER ➤ Try a Free Trial ➤ Try a Free Trial 2016
METFORMIN ER ➤ Try a Free Trial ➤ Try a Free Trial 2015
METFORMIN ER ➤ Try a Free Trial ➤ Try a Free Trial 2014
METFORMIN ER ➤ Try a Free Trial ➤ Try a Free Trial 2013
METFORMIN ER ➤ Try a Free Trial ➤ Try a Free Trial 2012
METFORMIN ER ➤ Try a Free Trial ➤ Try a Free Trial 2011
METFORMIN ER ➤ Try a Free Trial ➤ Try a Free Trial 2010
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Farmers Insurance
Julphar
Express Scripts
Moodys
Fuji
Cerilliant
Federal Trade Commission
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.